Schedule 13G ownership disclosure
Rigel Pharmaceuticals Inc
Common Stock · CUSIP: 766559702
Event date: 2024-12-31
- Filing-level shares
- 6,449.00
- Percent of class
- 0.0%
- Invesco Ltd.
Shares: 6,449.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-25-000056
- Form type
- SCHEDULE 13G/A
- Filer
- Invesco Ltd.
- CIK
- CIK 914208
- Filed
- Feb 07, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership